Back
Aptevo Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
40
APVO
Aptevo Therapeutics
Last Price:
0.27
Seasonality Move:
-10.33%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is relatively stagnant and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
Aptevo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.27 | Sell |
| 20-day SMA: | 0.24 | Buy |
| 50-day SMA: | 0.24 | Buy |
| 200-day SMA: | 1.81 | Sell |
| 8-day EMA: | 0.27 | Sell |
| 20-day EMA: | 0.25 | Buy |
| 50-day EMA: | 0.28 | Sell |
| 200-day EMA: | 6.03 | Sell |
Aptevo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 53.41 | Buy |
| Chaikin Money Flow: | -1887889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.17 - 0.29) | Buy |
| Bollinger Bands (100): | (0.21 - 0.43) | Sell |
Aptevo Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aptevo Therapeutics Stock
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 0.27 while APVO 8-day simple moving average is 0.27, which is a Sell signal.
- The stock price of APVO is 0.27 while Aptevo Therapeutics 20-day SMA is 0.24, which makes it a Buy.
- Aptevo Therapeutics 50-day simple moving average is 0.24 while APVO share price is 0.27, making it a Buy technically.
- APVO stock price is 0.27 and Aptevo Therapeutics 200-day simple moving average is 1.81, creating a Sell signal.
APVO Technical Analysis vs Fundamental Analysis
Sell
40
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy or a Sell?
-
Aptevo Therapeutics stock is rated a Sell
The current Aptevo Therapeutics [APVO] share price is $0.27. The Score for APVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Aptevo Therapeutics Stock Info
Market Cap:
2.56M
Price in USD:
0.27
Share Volume:
2.82M
Aptevo Therapeutics 52-Week Range
52-Week High:
10.80
52-Week Low:
0.14
Sell
40
Aptevo Therapeutics (APVO)
is a Sell
Aptevo Therapeutics Share Price Forecast
-
What is the Aptevo Therapeutics stock price today?
The Aptevo Therapeutics stock price is 0.27 USD today. -
Will APVO stock go up or go down?
Aptevo Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aptevo Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aptevo Therapeutics is overvalued.
Is Aptevo Therapeutics Stock a Buy?
- Aptevo Therapeutics share price is 0.27 while APVO 8-day exponential moving average is 0.27, which is a Sell signal.
- The stock price of APVO is 0.27 while Aptevo Therapeutics 20-day EMA is 0.25, which makes it a Buy.
- Aptevo Therapeutics 50-day exponential moving average is 0.28 while APVO share price is 0.27, making it a Sell technically.
- APVO stock price is 0.27 and Aptevo Therapeutics 200-day simple moving average is 6.03, creating a Sell signal.
Fundamental Analysis of Aptevo Therapeutics
Is Aptevo Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $94.93 per share, and an increase next year of $1.80 per share.
Technical Analysis of Aptevo Therapeutics
Should I short Aptevo Therapeutics stock?
- APVO Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Aptevo Therapeutics is a Buy
- Aptevo Therapeutics Relative Strength Index (RSI) is 53.41, which suggest Aptevo Therapeutics is overbought
- The Bollinger Bands (25) for Aptevo Therapeutics is (0.17 - 0.29), which suggest Aptevo Therapeutics is a Sell
- The Bollinger Bands (100) for Aptevo Therapeutics is (0.21 - 0.43), which suggest Aptevo Therapeutics is a Sell
* Aptevo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.